Rapid evaporative ionisation mass spectrometry (“REIMS”) and desorption electrospray ionisation mass spectrometry (“DESI-MS”) analysis of swabs and biopsy samples

Patent metadata

Field	Value
Publication number	US-10026599-B2
Application number	US-201615555783-A
Country	US
Kind code	B2
Filing date	Mar 7, 2016
Priority date	Mar 6, 2015
Publication date	Jul 17, 2018
Grant date	Jul 17, 2018

Abstract

A method is disclosed comprising providing a biological sample on a swab, directing a spray of charged droplets onto a surface of the swab in order to generate a plurality of analyte ions, and analyzing the analyte ions.

First claim

The invention claimed is:

1. A method comprising:
providing a biological sample on a swab, wherein said swab has been chemically modified to enhance selectivity for an analyte;
directing a spray of charged droplets onto a surface of said swab in order to generate a plurality of analyte ions, wherein directing said spray of charged droplets onto said swab comprises ionising said sample using Desorption Electrospray Ionisation (“DESI”) or desorption electroflow focusing ionisation (“DEFFI”);
mass analysing and/or ion mobility analysing said analyte ions or ions derived from said analyte ions in order to obtain mass spectrometric and/or ion mobility data; and
analysing said mass spectrometric data and/or said ion mobility data.

2. The method as claimed in claim 1 , wherein the step of analysing said mass spectrometric data and/or said ion mobility data comprises using one or more of: (i) univariate analysis; (ii) multivariate analysis; (iii) principal component analysis (PCA); (iv) linear discriminant analysis (LDA); (v) maximum margin criteria (MMC); (vi) library-based analysis; (vii) soft independent modelling of class analogy (SIMCA); (viii) factor analysis (FA); (ix) recursive partitioning (decision trees); (x) random forests; (xi) independent component analysis (ICA); (xii) partial least squares discriminant analysis (PLS-DA); (xiii) orthogonal (partial least squares) projections to latent structures (OPLS); (xiv) OPLS discriminant analysis (OPLS-DA); (xv) support vector machines (SVM); (xvi) (artificial) neural networks; (xvii) multilayer perceptron; (xviii) radial basis function (RBF) networks; (xix) Bayesian analysis; (xx) cluster analysis; (xxi) a kernelized method; and (xxii) subspace discriminant analysis; (xxiii) k-nearest neighbours (KNN); (xxiv) quadratic discriminant analysis (QDA); (xxv) probabilistic principal component Analysis (PPCA); (xxvi) non negative matrix factorisation; (xxvii) k-means factorisation; (xxviii) fuzzy c-means factorisation; and (xxix) discriminant analysis (DA).

3. The method as claimed in claim 1 , wherein said chemical modification renders said swab lipophilic.

4. The method as claimed in claim 1 , wherein said chemical modification involves formation of a coating on a surface of the swab.

5. The method as claimed in claim 4 , wherein said coating is a polymeric coating.

6. The method as claimed in claim 5 , wherein said polymer coating comprises polydivinylbenzene (DVB), a copolymer of N-vinylpyrrolidone and divinylbenzene, or polydimethylsiloxane.

7. The method as claimed in claim 5 , wherein said polymeric coating contains particles of a solid-phase extraction material.

8. The method as claimed in claim 1 , wherein said chemical modification utilises a solid-phase extraction material.

9. The method as claimed in claim 8 , wherein said solid-phase extraction material comprises polymer particles, silica particles, hybrid silica/organic particles, carbon particles or polymer-coated solid particles.

10. The method as claimed in claim 1 , comprising directing said spray of charged droplets onto said swab from a sprayer.

11. The method as claimed in claim 10 , further comprising providing said sprayer with a solvent at a flow rate in the range (i) <5 μL/min; (ii) 5-7 μL/min; (iii) 7-9 μL/min; (iv) 9-10 μL/min; (v) 10-11 μL/min; (vi) 11-13 μL/min; (vii) 13-15 μL/min; or (viii) 15-20 μL/min.

12. The method as claimed in claim 1 , further comprising rotating said swab whilst directing said spray of charged droplets onto said surface of said swab, optionally wherein said step of rotating said swab whilst directing said spray of charged droplets onto said surface of said swab comprises substantially continuously rotating said swab whilst directing said spray of charged droplets onto said surface of said swab.

13. The method as claimed in claim 1 , further comprising translating and/or oscillating said swab whilst directing said spray of charged droplets onto said surface of said swab, optionally wherein said step of translating and/or oscillating said swab comprises substantially continuously translating and/or oscillating said swab whilst directing said spray of charged droplets onto said surface of said swab.

14. The method as claimed in claim 1 , wherein the step of analysing said mass spectrometric data and/or said ion mobility data comprises performing a supervised and/or unsupervised analysis of said mass spectrometric data.

15. An apparatus comprising:
a first device arranged and adapted to direct a spray of charged droplets onto a surface of a swab in order to generate a plurality of analyte ions, wherein said first device comprises a Desorption Electrospray Ionisation (“DESI”) ion source or a desorption electroflow focusing ionisation (“DEFFI”) ion source and wherein said swab has been chemically modified to enhance selectivity for an analyte; and
a mass analyser and/or ion mobility analyser for mass analysing and/or ion mobility analysing said analyte ions or ions derived from said analyte ions in order to obtain mass spectrometric and/or ion mobility data.

16. The apparatus as claimed in claim 15 , wherein said mass spectrometric data and/or ion mobility data is analysed using one or more of: (i) univariate analysis; (ii) multivariate analysis; (iii) principal component analysis (PCA); (iv) linear discriminant analysis (LDA); (v) maximum margin criteria (MMC); (vi) library-based analysis; (vii) soft independent modelling of class analogy (SIMCA); (viii) factor analysis (FA); (ix) recursive partitioning (decision trees); (x) random forests; (xi) independent component analysis (ICA); (xii) partial least squares discriminant analysis (PLS-DA); (xiii) orthogonal (partial least squares) projections to latent structures (OPLS); (xiv) OPLS discriminant analysis (OPLS-DA); (xv) support vector machines (SVM); (xvi) (artificial) neural networks; (xvii) multilayer perceptron; (xviii) radial basis function (RBF) networks; (xix) Bayesian analysis; (xx) cluster analysis; (xxi) a kernelized method; and (xxii) subspace discriminant analysis; (xxiii) k-nearest neighbours (KNN); (xxiv) quadratic discriminant analysis (QDA); (xxv) probabilistic principal component Analysis (PPCA); (xxvi) non negative matrix factorisation; (xxvii) k-means factorisation; (xxviii) fuzzy c-means factorisation; and (xxix) discriminant analysis (DA).

Assignees

• Micromass Ltd

Inventors

• Takats Zoltan
• Jones Emrys
• Langridge James Ian
• Morris Michael Raymond
• Karancsi Tamas
• Pringle Steven Derek
• Balog Julia
• Simon Daniel
• Godorhazy Lajos
• Szalay Daniel
• Richardson Keith
• Bennett Phillip Robert
• Macintyre David Alan
• Pruski Pamela

Classifications

• G01N33/92

  involving lipids, e.g. cholesterol {, lipoproteins, or their receptors (steroid hormones G01N33/743)} · CPC title

• A61B5/015

  By temperature mapping of body part · CPC title

• C12Q1/025

  for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics (antimicrobial activity C12Q1/18) · CPC title

• A61B5/0075

  by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence) · CPC title

• A61B1/041

  Capsule endoscopes for imaging · CPC title